Tiny study aims to predict which throat lesions turn cancerous

NCT ID NCT07508319

Recruiting now Knowledge-focused Sponsor: European Institute of Oncology Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at genetic and immune changes in laryngeal dysplasia, a precancerous condition of the voice box. Researchers will compare tissue samples from 3 patients to see if certain immune cells (TILs) differ between low-risk and high-risk lesions. The goal is to find markers that predict progression to cancer, which could improve monitoring and early treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this research could help identify which patients with laryngeal dysplasia are at highest risk of developing cancer, enabling earlier intervention.
What could go wrong: This is a very small, early observational study with only 3 participants. It is not testing a treatment, so it may not lead directly to any new therapy or change in care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEAD NECK CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

head and neck cancer Head and Neck Neoplasms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEAD NECK CANCER

Contacts and locations

Locations

European Institute of Oncology
RECRUITING

Milan, MI, 20141, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.